DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0)

Metabolite details

Identifier

KRECEGQUDDMNAQ-MYBRWWDOSA-N

InChI Key

KRECEGQUDDMNAQ-MYBRWWDOSA-N

IUPAC name

Preferred name

DG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/0:0)

INN name

—

Synonym

DG(18:2/20:4)

ChEBI

CHEBI:89203

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2.
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

Observed in differential profiles

• non_COVID_19_healthy_vs_non_critical_COVID_19
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Mild_vs_Severe